Publication | Open Access

Poly(ethylene glycol) modification of β-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs

Ethylene GlycolDrug TargetingNanotherapeuticsPolymer-drug ConjugateMedicineGlycobiologyGlucuronide ProdrugsAntibody EngineeringImmunotherapeuticsTumor TargetingImmunotherapyPharmacologyRadiation OncologySolid-tumor TherapyBiomolecular Engineering